Interleukin-10 determines viral clearance or persistence in vivo

Nature Medicine

Volumn 12, Issue 11, 2006, Pages 1301-1309

  Brooks, David G ^a   Trifilo, Matthew J ^a   Edelmann, Kurt H ^a   Teyton, Luc ^a   McGavern, Dorian B ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 10 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GENE DELETION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HEPACIVIRUS; HIV; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; RECEPTORS, INTERLEUKIN-10; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33750499311     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1492     Document Type: Article

References (48)

1. Brooks, D.G., Teyton, L., Oldstone, M.B. & McGavern, D.B. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79, 10514-10527 (2005).
2. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
3. Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512 (2000).
4. Rosenberg, E.S. et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523-526 (2000).
5. Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395-1406 (2001).
6. Zajac, A.J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205-2213 (1998).
7. Ou, R., Zhou, S., Huang, L. & Moskophidis, D. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75, 8407-8423 (2001).
8. van der Most, R.G. et al. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240, 158-167 (1998).
9. Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911-4927 (2003).
10. Klenerman, P. & Hill, A. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6, 873-879 (2005).
11. Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687 (2005).
12. Borrow, P. & Oldstone, M.B. Lymphocytic choriomeningitis virus. In Viral Pathogenesis (ed. Nathanson, N.) 593-627 (Lippincott-Raven, Philadelphia, 1997).
13. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M. & Oldstone, M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521-540 (1984).
14. Borrow, P., Evans, C.F. & Oldstone, M.B. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69, 1059-1070 (1995).
15. Salvato, M., Borrow, P., Shimomaye, E. & Oldstone, M.B. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65, 1863-1869 (1991).
16. Sevilla, N. et al. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192, 1249-1260 (2000).
17. Fuller, M.J., Khanolkar, A., Tebo, A.E. & Zajac, A.J. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172, 4204-4214 (2004).
18. Fiorentino, D.F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451 (1991).
19. Groux, H., Bigler, M., de Vries, J.E. & Roncarolo, M.G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184, 19-29 (1996).
20. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
21. Clerici, M. et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88, 574-579 (1996).
22. Orsilles, M.A., Pieri, E., Cooke, P. & Caula, C. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. APMIS 114, 55-60 (2006).
23. Cacciarelli, T.V., Martinez, O.M., Gish, R.G., Villanueva, J.C. & Krams, S.M. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 24, 6-9 (1996).
24. Brady, M.T., MacDonald, A.J., Rowan, A.G. & Mills, K.H. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur. J. Immunol. 33, 3448-3457 (2003).
25. Dolganiuc, A. et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170, 5615-5624 (2003).
26. Marin-Serrano, E., Rodriguez-Ramos, C., Diaz, F., Martin-Herrera, L. & Giron-Gonzalez, J.A. Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J. Viral Hepat. 13, 230-234 (2006).
27. Rico, M.A. et al. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33, 295-300 (2001).
28. Clerici, M. et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93, 768-775 (1994).
29. Landay, A.L. et al. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J. Infect. Dis. 173, 1085-1091 (1996).
30. Rigopoulou, E.I., Abbott, W.G., Haigh, P. & Naoumov, N.V. Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117, 57-64 (2005).
31. Lin, M.T., Hinton, D.R., Parra, B., Stohlman, S.A. & van der Veen, R.C. The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245, 270-280 (1998).
32. Strestik, B.D., Olbrich, A.R., Hasenkrug, K.J. & Dittmer, U. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus). J. Gen. Virol. 82, 1349-1354 (2001).
33. Day, C.L. et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354 (2006).
34. Trautmann, L. et al. Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction. Nat. Med. advance online publication, 20 August 2006 (doi:10.1038/nm1482).
35. + T cell responses induced by dendritic cells generated in the presence of IFN-α. J. Immunol. 172, 7832-7840 (2004).
36. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F.P. & Steinman, R.M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 101, 7669-7674 (2004).
37. Ji, J., Sahu, G.K., Braciale, V.L. & Cloyd, M.W. HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int. Immunol. 17, 729-736 (2005).
38. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331-343 (2004).
39. Lechmann, M. et al. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J. Hepatol. 31, 971-978 (1999).
40. + T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-γ and interleukin-10 responses. J. Infect. Dis. 184, 1268-1278 (2001).
41. Tsai, S.L., Liaw, Y.F., Chen, M.H., Huang, C.Y. & Kuo, G.C. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25, 449-458 (1997).
42. Battegay, M. et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Virol. 68, 4700-4704 (1994).
43. Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063 (1994).
44. Tishon, A., Lewicki, H., Rall, G., Von Herrath, M. & Oldstone, M.B. An essential role for type 1 interferon-γ in terminating persistent viral infection. Virology 212, 244-250 (1995).
45. Brooks, D.G., McGavern, D.B. & Oldstone, M.B. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J. Clin. Invest. 116, 1675-1685 (2006).
46. + T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113, 963-972 (2004).
47. + T-cell memory. Nat. Med. 7, 913-919 (2001).
48. Zuniga, E.I., McGavern, D.B., Pruneda-Paz, J.L., Teng, C. & Oldstone, M.B. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 5, 1227-1234 (2004).